The term tailor-made or personalised medicine covers a form of drug treatment in which the use of drugs is adapted to the individual patient’s special …
In recent years, the pharma industry has seen significant growth in finding new uses for old drugs. The repurposing and repositioning of existing drugs have …
This article explores the legislative and economic drivers of why the industry needs to adapt, and crucially why now is the time to act. It …
Developers of medical devices are taking inspiration from consumer products use of connected technology; realising that smarter devices offer huge benefits to patients, POC workers, …
Drug developers work tirelessly, progressing their compounds from the laboratory to the clinical phases, and rigorously assessing the medication use in Phase II and Phase …
The purpose of first-in-human (FIH) studies is to evaluate the pharmacology, tolerability, and safety of the drug or investigational medicinal product in humans for the …
2020 was an extraordinary year for the whole of humanity. But for the clinical research sector, it has proved to be particularly defining. Rising financial …
The presence of bacterial endotoxins in different media, solutions and laboratory materials can be determined by utilising the limulus amebocyte lysate test. Lisa Komski at …
To understand the challenges that the pharmaceutical industry faces during COVID-19, open-ended interviews were conducted with top pharmaceutical companies around Europe. The methodology followed during …
2020 has redefined healthcare for good. As with many industries, the impact of COVID-19 cannot be understated, as healthcare was placed at the centre of …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative